General
Preferred name
URIDINE
Synonyms
¦Â-Uridine ()
??Uridine ()
NSC 20256,¦Â-Uridine, Uridin ()
NSC-20256 ()
1-.beta.-d-ribofuranosyluracil ()
Uracil riboside ()
Uridine-d2 ()
P&D ID
PD000785
CAS
58-96-8
12693-39-9
21231-59-4
40632-21-1
Tags
available
drug
Drug indication
Lung cancer
Depression
Drug Status
approved
experimental
investigational
Max Phase
3.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Uridine is a drug used to manage neuropsychiatric deficits associated with cerebrovascular diseases in combination with cytidine.
(Enamine Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
1
Compound Sets
17
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugMAP
DrugMAP Approved Drugs
Enamine Bioactive Compounds
Enamine BioReference Compounds
Guide to Pharmacology
NCATS Inxight Approved Drugs
ReFrame library
Selleckchem Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
51
Molecular Weight
244.07
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
4
Rotatable Bonds
2
Ring Count
2
Aromatic Ring Count
1
cLogP
-2.85
TPSA
124.78
Fraction CSP3
0.56
Chiral centers
4.0
Largest ring
6.0
QED
0.44
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
LSM6, TYMP
DNA/RNA Synthesis
MOA
Dopamine Receptor agonist
Source data
